These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies. Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899 [TBL] [Abstract][Full Text] [Related]
5. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling. Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563 [TBL] [Abstract][Full Text] [Related]
6. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984 [TBL] [Abstract][Full Text] [Related]
7. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome. Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683 [TBL] [Abstract][Full Text] [Related]
8. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331 [TBL] [Abstract][Full Text] [Related]
9. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome]. Zhang FC; Liu L; Xu D Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303 [TBL] [Abstract][Full Text] [Related]
10. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun. Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F Lupus; 2007; 16(1):10-7. PubMed ID: 17283579 [TBL] [Abstract][Full Text] [Related]
11. SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjögren's syndrome. Tsay GJ; Wang CL; Chen TY; Huang CN; Hsu TC J Formos Med Assoc; 1996 Dec; 95(12):905-10. PubMed ID: 9000806 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Liew MS; Zhang M; Kim E; Akpek EK Br J Ophthalmol; 2012 Dec; 96(12):1498-503. PubMed ID: 23001257 [TBL] [Abstract][Full Text] [Related]
13. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study. Yang Y; Li Z; Wang L; Zhang F Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641 [TBL] [Abstract][Full Text] [Related]
14. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases. Yamagata H; Akizuki M; Tojo T; Homma M Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876 [TBL] [Abstract][Full Text] [Related]
15. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302 [TBL] [Abstract][Full Text] [Related]
16. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome. Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389 [TBL] [Abstract][Full Text] [Related]
17. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome. Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838 [TBL] [Abstract][Full Text] [Related]
18. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428 [TBL] [Abstract][Full Text] [Related]
19. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]. Meyer O Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426 [TBL] [Abstract][Full Text] [Related]
20. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome? Scofield AN; Kurien BT; Gordon TP; Scofield RH Lupus; 2001; 10(8):547-53. PubMed ID: 11530996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]